Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes

Genes and Immunity

Volumn 13, Issue 7, 2012, Pages 530-535

  Banlaki Z ^a   Doleschall, M ^a   Rajczy, K ^b   Fust, G ^a   Szilagyi A ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b National Blood Transfusion Service   (Hungary)

Author keywords

ancestral haplotype; C4; copy number variation; CYP21A2; MHC; RCCX

Indexed keywords

COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; ELONGATION FACTOR 2 KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN; STEROID 21 MONOOXYGENASE; TENASCIN; TENASCIN X; UNCLASSIFIED DRUG;

ARTICLE; COPY NUMBER VARIATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPLEMENT C4A; COMPLEMENT C4B; DNA COPY NUMBER VARIATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; STEROID 21-HYDROXYLASE;

EID: 84867743913     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.29     Document Type: Article

References (43)

1. Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004; 56: 321-332.
2. Blanchong CA, Zhou B, Rupert KL, Chung EK, Jones KN, Sotos JF et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000; 191: 2183-2196.
3. Yang Y, Chung EK, Zhou B, Blanchong CA, Yu CY, Fust G et al. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol 2003; 171: 2734-2745.
4. Dodds AW, Ren XD, Willis AC, Law SK. The reaction mechanism of the internal thioester in the human complement component C4. Nature 1996; 379: 177-179.
5. Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004; 7: 98-132.
6. Szilagyi A, Fust G. Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 2008; 123: 118-130.
7. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291.
8. Brellier F, Tucker RP, Chiquet-Ehrismann R. Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports 2009; 19: 511-519.
9. Lehner B, Semple JI, Brown SE, Counsell D, Campbell RD, Sanderson CM. Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region. Genomics 2004; 83: 153-167.
10. Saxena K, Kitzmiller KJ, Wu YL, Zhou B, Esack N, Hiremath L et al. Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations. Mol Immunol 2009; 46: 1289-1303.
11. Chung EK, Yang Y, Rupert KL, Jones KN, Rennebohm RM, Blanchong CA et al. Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002; 71: 810-822.
12. Yunis EJ, Larsen CE, Fernandez-Vina M, Awdeh ZL, Romero T, Hansen JA et al. Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens 2003; 62: 1-20.
13. Szilagyi A, Banlaki Z, Pozsonyi E, Yunis EJ, Awdeh ZL, Hosso A et al. Frequent occurrence of conserved extended haplotypes (CEHs) in two Caucasian populations. Mol Immunol 2010; 47: 1899-1904.
14. Bánlaki Z, Szabó JA, Szilágyi Á, Patócs A, Prohászka Z, Füst G et al. Intraspecific evolution of human RCCX copy number variation traced by the haplotypes of CYP21A2 gene (Submitted).
15. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007; 80: 1037-1054.
16. Dorak MT, Shao W, Machulla HK, Lobashevsky ES, Tang J, Park MH et al. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun 2006; 7: 450-467.
17. Chu X, Braun-Heimer L, Rittner C, Schneider PM. Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA-B47,DR7 haplotype. Exp Clin Immunogenet 1992; 9: 80-85.
18. Valente FP, Tan C, Phipps M, Witt CS, Kaur G, Gut I et al. TNF block haplotypes associated with conserved MHC haplotypes in European, Asian and Australian Aboriginal donors. Tissue Antigens 2009; 74: 57-61.
19. Chung EK, Yang Y, Rennebohm RM, Lokki ML, Higgins GC, Jones KN et al. Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet 2002; 71: 823-837.
20. Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 2008; 60: 1-18.
21. Wu YL, Yang Y, Chung EK, Zhou B, Kitzmiller KJ, Savelli SL et al. Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 2008; 123: 131-141.
22. Lee HH. Diversity of the CYP21P-like gene in CYP21 deficiency. DNA Cell Biol 2005; 24: 1-9.
23. Lee HH, Tsai FJ, Lee YJ, Yang YC. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P. Mol Genet Metab 2006; 88: 372-377.
24. Koppens PF, Hoogenboezem T, Degenhart HJ. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet 2002; 111: 405-410.
25. Wu YL, Savelli SL, Yang Y, Zhou B, Rovin BH, Birmingham DJ et al. Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J Immunol 2007; 179: 3012-3025.
26. Laki J, Kiszel P, Vatay A, Blasko B, Kovacs M, Korner A et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of-429 T4C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the-429C allele with high hemoglobinA1C levels in diabetic patients. Mol Immunol 2007; 44: 648-655.
27. Vatay A, Yang Y, Chung EK, Zhou B, Blanchong CA, Kovacs M et al. Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Hum Immunol 2003; 64: 543-552.
28. Baumgartner-Parzer SM, Fischer G, Vierhapper H. Predisposition for de novo gene aberrations in the offspring of mothers with a duplicated CYP21A2 gene. J Clin Endocrinol Metab 2007; 92: 1164-1167.
29. Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA et al. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 2006; 55: 1265-1269.
30. Candore G, Campagna AM, Cuppari I, Di Carlo D, Mineo C, Caruso C. Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases. Ann N Y Acad Sci 2007; 1110: 151-158.
31. Corvol H, Beucher J, Boelle PY, Busson PF, Muselet-Charlier C, Clement A et al. Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. J Cyst Fibros 2012; 11: 63-67.
32. Rojana-udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ et al. The association of sporadic inclusion body myositis and Sjogren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 2011; 113: 559-563.
33. Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308 A, and risk of non-Hodgkin lymphoma. Leukemia 2010; 24: 1055-1058.
34. Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK et al. IgA deficiency and the MHC: assessment of relative risk and micro-heterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol 2010; 30: 138-143.
35. Mao R, McDonald J, Cantwell M, Tang W, Ward K. The implication of de novo 21-hydroxylase mutation in clinical and prenatal molecular diagnoses. Genet Test 2005; 9: 121-125.
36. Muers M. Complex disease: ups and downs at the MHC. Nat Rev Genet 2011; 12: 456-457.
37. Traherne JA. Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet 2008; 35: 179-192.
38. Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 2003; 73: 214-217.
39. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H et al. Confirmation of the association of the C4B null allelle in autism. Hum Immunol 2005; 66: 140-145.
40. Mayilyan KR, Dodds AW, Boyajyan AS, Soghoyan AF, Sim RB. Complement C4B protein in schizophrenia. World J Biol Psychiatry 2008; 9: 225-230.
41. Zafar GI, Grimm EA, Wei W, Johnson MM, Ellerhorst JA. Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma. J Urol 2009; 181: 1028-1034; discussion 34.
42. Szilagyi A, Blasko B, Szilassy D, Fust G, Sasvari-Szekely M, Ronai Z. Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet 2006; 7: 1.
43. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1: 47-50.